C4 Therapeutics Entered into an Exclusive License Agreement with Betta to Develop and Commercialize CFT8919 for Non-Small Cell Lun...
Shots: C4T will receive $35M incl. $10M up front & $25M one-time equity invest...
InDex Pharmaceuticals Entered into a License Agreement with Viatris to Develop and Commercialize Cobitolimod for Ulcerative Coliti...
Shots: InDex will receive $10M up front for the exclusive rights to commercialize...
Stealth BioTherapeutics Entered into an Exclusive License Agreement with Pharmanovia to Commercialize Elamipretide for Barth Syndr...
Shots: Stealth will receive up front, development, regulatory & commercial mil...
Sun Pharma Entered into a License Agreement with Philogen to Commercialize Nidlegy for Skin Cancers
Shots: Sun Pharma to get an exclusive right to commercialize Nidlegy (developed by...
HanAll Biopharma and Daewoong Entered into Co-Development Agreement with NurrOn to Develop Novel Therapies for Parkinson's Disease
Shots: The companies collaborated to discover & develop novel therapies for pa...
Akebia Signs a License Agreement with Medice Arzneimittel Pütter GmbH&Co.KG to Commercialize Vafseo for Anemia Associated with CKD
Shots: Akebia will receive $10M up front, ~$100M in commercial milestones for righ...
